Insider Transactions Reported by 18 Insiders of Adicet Bio, Inc.

Symbol
ACET on Nasdaq
Industry
Pharmaceutical Preparations
Location
Boston, MA

Insiders trading volume in the past year

Adicet Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Orbimed Advisors Llc 10%+ Owner $4.49M +$5M Oct 8, 2025
Carl L. Gordon Director, 10%+ Owner $942K Aug 21, 2024
Francesco Galimi SVP & Chief Medical Officer $244K Jun 5, 2024
Aya Jakobovits Director $214K Aug 21, 2024
Chen Schor President & CEO, Director $176K Jan 31, 2025
Brian Nicholas Harvey Chief Financial Officer $83.9K Jan 31, 2025
Lloyd Klickstein Director $66.2K Jun 11, 2025
Don Healey Chief Technology Officer $58.8K Jan 31, 2025
Blake Aftab Chief Scientific Officer $51.8K Jan 31, 2025
Steve Dubin Director $13.8K Jun 11, 2025
Andrew Sinclair Director $10.8K Jun 11, 2025
Jeffrey Chodakewitz Director $10.8K Jun 11, 2025
Michael Kauffman Director $8.44K Aug 21, 2024
Katie Peng Director $7.2K Jun 11, 2025
Julia D. Maltzman Chief Medical Officer Jan 31, 2025
Michael Grissinger Director Apr 17, 2025
Stewart Abbot Former Chief Scientific and Operating Officer Jun 11, 2021
Bastiano Sanna Director Aug 14, 2023

Recent Insider Transactions by Companies or Individuals for Adicet Bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.